Department of Medicine E, Rabin Medical Center, Belinson Hospital, Ramat Aviv, Israel.
J Clin Microbiol. 2010 Feb;48(2):489-96. doi: 10.1128/JCM.01636-09. Epub 2009 Dec 9.
The use of molecular-based methods for the diagnosis of bacterial infections in blood is appealing, but they have not yet passed the threshold for clinical practice. A systematic review of prospective and case-control studies assessing the diagnostic utility of PCR directly with blood samples for the diagnosis of invasive pneumococcal disease (IPD) was performed. A broad search was conducted to identify published and unpublished studies. Two reviewers independently extracted the data. Summary estimates for sensitivity and specificity with 95% confidence intervals (CIs) were calculated by using the hierarchical summary receiver operating characteristic method. The effects of sample processing, PCR type, the gene-specific primer, study design, the participants' age, and the source of infection on the diagnostic odds ratios were assessed through meta-regression. Twenty-nine studies published between 1993 and 2009 were included. By using pneumococcal bacteremia for case definition and healthy people or patients with bacteremia caused by other bacteria as controls (22 studies), the summary estimates for sensitivity and specificity were 57.1% (95% CI, 45.7 to 67.8%) and 98.6% (95% CI, 96.4 to 99.5%), respectively. When the controls were patients suspected of having IPD without pneumococcal bacteremia (26 studies), the respective values were 66.4% (95% CI, 55.9 to 75.6%) and 87.8% (95% CI, 79.5 to 93.1%). With lower degrees of proof for IPD (any culture or serology result and the clinical impression), the sensitivity of PCR decreased and the specificity increased. All analyses were highly heterogeneous. The use of nested PCR and being a child were associated with low specificity, while the use of a cohort study design was associated with a low sensitivity. The lack of an appropriate reference standard might have caused underestimation of the performance of the PCR. Currently available methods for PCR with blood samples for the diagnosis of IPD lack the sensitivity and specificity necessary for clinical practice.
血液中细菌感染的分子检测方法很有吸引力,但尚未达到临床应用的标准。我们对直接采用血样进行聚合酶链反应(PCR)诊断侵袭性肺炎球菌病(IPD)的前瞻性和病例对照研究进行了系统评价。广泛搜索以确定已发表和未发表的研究。两位评审员独立提取数据。使用分层汇总受试者工作特征曲线方法计算灵敏度和特异性的汇总估计值及 95%置信区间(CI)。通过元回归评估样本处理、PCR 类型、基因特异性引物、研究设计、患者年龄以及感染源对诊断优势比的影响。纳入了 1993 年至 2009 年期间发表的 29 项研究。采用肺炎球菌菌血症作为病例定义,以健康人群或由其他细菌引起菌血症的患者作为对照(22 项研究),灵敏度和特异性的汇总估计值分别为 57.1%(95%CI,45.7 至 67.8%)和 98.6%(95%CI,96.4 至 99.5%)。当对照为疑似患有 IPD 而无肺炎球菌菌血症的患者(26 项研究)时,相应的数值分别为 66.4%(95%CI,55.9 至 75.6%)和 87.8%(95%CI,79.5 至 93.1%)。在 IPD 的证明程度较低(任何培养物或血清学结果和临床印象)时,PCR 的灵敏度降低,特异性增加。所有分析均高度异质。巢式 PCR 的使用和儿童患者与较低的特异性相关,而队列研究设计与较低的灵敏度相关。缺乏适当的参考标准可能导致对 PCR 性能的低估。目前用于血液样本检测 IPD 的 PCR 方法在灵敏度和特异性方面都无法满足临床应用的需要。